In patients over 40 years of age with previous elective non-cardiac surgery, NT-proBNP levels equal to or higher than 125 pg/ml were independently associated with a diagnosis of lung cancer after excluding patients with heart failure, CAD, and other conditions known to affect this biomarker [22]. This evidence concerns the gene NPPB and lung carcinoma.